Results 291 to 300 of about 88,529 (348)

The RANK/RANKL axis controls vascular dynamics in the bone marrow. [PDF]

Proc Natl Acad Sci U S A
Kaneko T, Yari S, Kikuta J, Omatsu Y, Seno S, Kikuchi S, Sato K, Fujii K, Sudo T, Hasegawa T, Furuta K, Guo Q, Ibrahim SH, Muraoka K, Okada Y, Kubota Y, Okuzaki D, Kobayashi Y, Kumanogoh A, Udagawa N, Nagasawa T, Penninger JM, Ishii M.   +22 more
europepmc   +1 more source

Decoding Epigenetic Switches: How Histone Acetylation/Deacetylation Regulates Mononuclear/Macrophage Fate in Bone Disorders. [PDF]

Int J Biol Sci
Xu L, Shen C, Liu X, Qin Y, Wu Z, Zhang Z, Sheng Q, Wang Q, Zhou F, Ge G, Geng D.   +10 more
europepmc   +1 more source

Reconceptualizing Peri‐Implantitis: Dual‐Factor Inflammation and Its Role in Advancing Biomaterial Coatings

Clinical Implant Dentistry and Related Research, Volume 28, Issue 1, February 2026.
Daniela Moreira Cunha, Amanda Paino Santana, Mariana Martins Guerreiro, Akhilanand Chaurasia, Anton Sculean, Rafael Scaf de Molon, Erica Dorigatti de Avila   +6 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

RANKL biology

Bone, 2022
Since the receptor activator of nuclear factor-kappa B ligand (RANKL), its cognate receptor activator of nuclear factor-kappa B (RANK), and the decoy receptor osteoprotegerin (OPG) were discovered, a number of studies have uncovered the crucial role of the RANKL-RANK-OPG pathway in controlling the key aspect of bone homeostasis, the immune system ...
Noriko, Takegahara, Hyunsoo, Kim, Yongwon, Choi   +2 more
openaire   +2 more sources

Relationship between serum RANKL and RANKL in bone

Osteoporosis International, 2011
It is now well accepted that the molecule receptor activator of NFκB ligand (RANKL) and osteoprotegerin play key roles in regulating physiological and pathological bone turnover. There are a large number of published reports of circulating RANKL levels in both health and pathology.
Findlay, D., Atkins, G.
openaire   +3 more sources

RANKL/RANK—beyond bones

Journal of Molecular Medicine, 2011
Receptor-activator of NF-κB ligand (TNFSF11, also known as RANKL, OPGL, TRANCE, and ODF) and its tumor necrosis factor (TNF)-family receptor RANK are essential regulators of bone remodeling, lymph node formation, establishment of the thymic microenvironment, mammary gland development during pregnancy, and bone metastasis in cancer.
Hanada, R., Hanada, T. Sigl, V, Schramek, D., and J. M. Penninger..   +7 more
openaire   +2 more sources